Chuck Kumban Walter, Hwang Minji, Choi Kui Son, Suh Mina, Jun Jae Kwan, Park Boyoung
Department of Cancer Control and Population Health, National Cancer Center Graduate School of Cancer Science and Policy, Goyang, Korea.
Research Center, National Cancer Center, Goyang, Korea.
Epidemiol Health. 2017 Aug 10;39:e2017036. doi: 10.4178/epih.e2017036. eCollection 2017.
To investigate the screening rates for gastric, breast, and cervical cancer in people with diabetes compared with people without diabetes.
Data from the Korea National Health and Nutrition Examination Survey (2007-2009) were used. Cancer-free men who were 40 years old and over and cancer-free women who were 30 years old and over were included. The lifetime screening rate and regular screening rate were compared in people with and without diabetes.
Fewer people with diabetes than people without diabetes had ever received cancer screening (53.5 vs. 59.5%, p<0.001 for gastric cancer; 60.5 vs. 71.5%, p<0.001 for breast cancer; and 49.1 vs. 59.6%, p<0.001 for cervical cancer). Fewer people with diabetes than people without diabetes received the recommended screenings for gastric cancer (38.9 vs. 42.9%, p<0.001), breast cancer (38.8 vs. 44.6%, p<0.001), and cervical cancer (35.1 vs. 51.2%, p<0.001). In subgroup analyses according to socioeconomic factors, the lifetime and recommended screening rates were lower in the diabetic population in most socioeconomic subgroups. In the multivariate analysis adjusted for socioeconomic factors, people with diabetes showed lower lifetime screening rates for gastric and cervical cancer (odds ratio [OR], 0.8; 95% confidence interval [CI], 0.7 to 0.9 and OR, 0.7; 95% CI, 0.6 to 0.9), and lower regular screening rates for breast and cervical cancer (OR, 0.7; 95% CI, 0.6 to 0.9 and OR, 0.7; 95% CI, 0.5 to 0.9).
The cancer screening rate in people with diabetes was lower than in people without diabetes. Considering the higher cancer risk in people with diabetes, efforts to increase the screening rate in this high-risk population should be implemented.
调查糖尿病患者与非糖尿病患者的胃癌、乳腺癌和宫颈癌筛查率。
使用韩国国家健康与营养检查调查（2007 - 2009年）的数据。纳入40岁及以上无癌症的男性和30岁及以上无癌症的女性。比较糖尿病患者和非糖尿病患者的终生筛查率和定期筛查率。
糖尿病患者接受癌症筛查的人数少于非糖尿病患者（胃癌：53.5%对59.5%，p<0.001；乳腺癌：60.5%对71.5%，p<0.001；宫颈癌：49.1%对59.6%，p<0.001）。糖尿病患者接受推荐的胃癌筛查（38.9%对42.9%，p<0.001）、乳腺癌筛查（38.8%对44.6%，p<0.001）和宫颈癌筛查（35.1%对51.2%，p<0.001）的人数也少于非糖尿病患者。在根据社会经济因素进行分组分析时，大多数社会经济亚组中糖尿病患者的终生筛查率和推荐筛查率较低。在对社会经济因素进行调整的多变量分析中，糖尿病患者的胃癌和宫颈癌终生筛查率较低（优势比[OR]，0.8；95%置信区间[CI]，0.7至0.9以及OR，0.7；95%CI，0.6至0.9），乳腺癌和宫颈癌的定期筛查率较低（OR，0.7；95%CI，0.6至0.9以及OR，0.7；95%CI，0.5至0.9）。
糖尿病患者的癌症筛查率低于非糖尿病患者。鉴于糖尿病患者的癌症风险较高，应努力提高这一高危人群的筛查率。
